ArticleActa Cardiologica Sinica2025
The Impact of Insulin Resistance on the Development of Post-PCI Contrast-Induced Nephropathy in Non-Diabetic STEMI.
Article in Acta Cardiologica Sinica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Contrast-induced nephropathy (CIN) is a condition characterized by rapidly decreasing renal funciton following by the application of contrast material. Precutaneous coronary intervention (PCI) is a life-saving treatment method that should be applied under emergent conditions. Unfortunately, the incidence of CIN after PCI is common. Patients with insulin resistance or diabetes have a greater risk of developing CIN than most of the population. Therefore, studies on the predictive effects of insulin resistance indicators on CIN are gaining momentum. One of the most popular indicators is triglyceride/glucose-body mass index (TyG-BMI). In this study we aimed to evaluate the effect of TyG-BMI index on CIN. Materials and Methods: A total of 960 patinets who underwent emergency PCI due to ST elevation myocardial infarction (STEMI) between 2020 and 2023 were included in the study. Laboratory and demographic parameters were compared between the patients who did and did not develop CIN. Results: While CIN developed in 120 of the 980 patients included in the study, it did not develop in 860 patients. There were significant differences between the groups in terms of age (p < 0.001), gender (p = 0.005), presence of hypertension (p = 0.021), heart rate (p = 0.049), amount of contrast material (p < 0.001), left ventricular ejection fraction (p < 0.001), stent length (p = 0.022), SYNTAX score (p < 0.001), fasting plasma glucose (p < 0.001), baseline creatinine (p < 0.001), glomerular filtration rate (p < 0.001), uric acid (p < 0.001), C reactive protein (CRP) (p < 0.001), baseline creatin kinase myocard band (CKMB) (p = 0.019), CKMB peak (p = 0.030), triglyceride (p = 0.017), and TyG-BMI (p < 0.001). CRP, creatinine, uric asid, amount of contrast material, and TyG-BMI were independent predictors for the development of CIN. Conclusions: TyG-BMI was a predictor of CIN in STEMI patient who underwent PCI under emergency conditions. In addition, the predicitive power of TyG-BMI was stronger than triglyceride-glucose index.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.